References
- Hermida RC, Ayala DE, Mojón A, Fernández JR. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol. Int.27(8), 1629–1651 (2010).
- Folgering JHA, Sharif-Naeini R, Dedman A, Patel A, Delmas P, Honoré E. Molecular basis of the mammalian pressure-sensitive ion channels: focus on vascular mechanotransduction. Progr. Biophys. Mol. Biol.97, 180–195 (2008).
- van Ramshorst J, Bax JJ, Beeres SL et al. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. JAMA301(19), 1997–2004 (2009).
- Joergensen C, Gall MA, Schmedes A, Tarnow L, Parving HH, Rossing P. Vitamin D levels and mortality in Type 2 diabetes. Diabetes Care33(10), 2238–2243 (2010).
- Nin JW, Jorsal A, Ferreira I et al. Higher plasma soluble receptor for advanced glycation end products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in Type 1 diabetes: a 12-year follow-up study. Diabetes59(8), 2027–2032 (2010).
Website
- ECCR – European Council for Cardiovascular Research www.eccr.org